The cell-based model of coagulation: State-Of-The-Art Review

Journal of Veterinary Emergency and Critical Care

Volumn 19, Issue 1, 2009, Pages 3-10

  Smith, Stephanie A ^a  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

Author keywords

Hemostasis; Microparticles; Platelets; Procoagulant membrane; Thrombin

Indexed keywords

BLOOD CLOTTING FACTOR;

ANIMAL; ARTICLE; BIOLOGICAL MODEL; BLOOD CLOTTING; HUMAN; METABOLISM; PHYSIOLOGY;

ANIMALS; BLOOD COAGULATION; BLOOD COAGULATION FACTORS; HUMANS; MODELS, BIOLOGICAL;

EID: 61449101394     PISSN: 14793261     EISSN: 14764431     Source Type: Journal    
DOI: 10.1111/j.1476-4431.2009.00389.x     Document Type: Article

References (25)

1. Furie B, Furie BC. In vivo thrombus formation. J Thromb Haemost 2007 5 (suppl 1) : 12 17.
2. Malone PC, Agutter PS. Coagulation and its disorders: A history of haematological research. The Aetiology of Deep Venous Thrombosis: A Critical, Historical and Epistemological Survey. Dordrecht : Springer 2008, pp. 57 70.
3. Hoffman M. Remodeling the blood coagulation cascade. J Thromb Thrombolysis 2003 16 (1-2) : 17 20.
4. Colman RW, Clowes AW, George JN, et al. Overview of hemostasis. Hemostasis and Thrombosis, 5th ed. Philadelphia : Lippincott Williams and Wilkins 2006, pp. 3 16.
5. Mann KG, Brummel K, Butenas S. What is all that thrombin for? J Thromb Haemost 2003 1 (7) : 1504 1514.
6. Roberts HR, Hoffman M, Monroe DM. A cell-based model of thrombin generation. Semin Thromb Hemost 2006 32 (suppl 1) : 32 38.
7. Becker RC. Cell-based models of coagulation: a paradigm in evolution. J Thromb Thrombolysis 2005 20 (1) : 65 68.
8. Gailani D, Renne T. The intrinsic pathway of coagulation: a target for treating thromboembolic disease? J Thromb Haemost 2007 5 (6) : 1106 1112.
9. Morrissey JH, Mutch NJ. Tissue factor structure and function. in Hemostasis and Thrombosis, 5th ed. Philadelphia : Lippincott Williams and Wilkins 2006, pp. 91 106.
10. Yamaji-Hasegawa A, Tsujimoto M. Asymmetric distribution of phospholipids in biomembranes. Biol Pharm Bull 2006 29 (8) : 1547 1553.
11. Piccin A, Murphy WG, Smith OP. Circulating microparticles: pathophysiology and clinical implications. Blood Rev 2007 21 (3) : 157 171.
12. Zwaal RF, Comfurius P, Bevers EM. Surface exposure of phosphatidylserine in pathological cells. Cell Mol Life Sci 2005 62 (9) : 971 988.
13. Neuenschwander PF, Bianco-Fisher E, Rezaie AR, et al. Phosphatidylethanolamine augments factor VIIa-tissue factor activity: enhancement of sensitivity to phosphatidylserine. Biochemistry 1995 34 (43) : 13988 13993.
14. Key NS, Geng JG, Bach RR. Tissue factor; from Morawitz to microparticles. Trans Am Clin Climatol Assoc 2007 118 : 165 173.
15. Morel O, Morel N, Freyssinet JM, et al. Platelet microparticles and vascular cells interactions: a checkpoint between the haemostatic and thrombotic responses. Platelets 2008 19 (1) : 9 23.
16. Sagripanti A, Carpi A. Antithrombotic and prothrombotic activities of the vascular endothelium. Biomed Pharmacother 2000 54 (2) : 107 111.
17. Levi M, ten Cate H, van der Poll T. Endothelium: interface between coagulation and inflammation. Crit Care Med 2002 30 (suppl 5) : S220 S224.
18. Schouten M, Wiersinga WJ, Levi M, et al. Inflammation, endothelium, and coagulation in sepsis. J Leukoc Biol 2008 83 (3) : 536 545.
19. Mackman N, Tilley RE, Key NS. Role of the extrinsic pathway of blood coagulation in hemostasis and thrombosis. Arterioscler Thromb Vasc Biol 2007 27 (8) : 1687 1693.
20. Morrissey JH. Plasma factor VIIa: measurement and potential clinical significance. Haemostasis 1996 26 (suppl 1) : 66 71.
21. Blomback B, Bark N. Fibrinopeptides and fibrin gel structure. Biophys Chem 2004 112 (2-3) : 147 151.
22. Nugent DJ. Prophylaxis in rare coagulation disorders - factor XIII deficiency. Thromb Res 2006 118 (suppl 1) : S23 S28.
23. Bouma BN, Mosnier LO. Thrombin activatable fibrinolysis inhibitor (TAFI) - how does thrombin regulate fibrinolysis? Ann Med 2006 38 (6) : 378 388.
24. Dutt T, Toh CH. The Yin-Yang of thrombin and activated protein C. Br J Haematol 2008 140 (5) : 505 515.
25. Oliver JA, Monroe DM, Church FC, et al. Activated protein C cleaves factor Va more efficiently on endothelium than on platelet surfaces. Blood 2002 100 (2) : 539 546.